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I . Executive Summary
The fight against malaria has yielded dramatic progress over the last 10–15 years . The World Health Organiza-
tion (WHO) estimates that the scale-up of malaria control interventions between 2001 and 2013 resulted in an 
estimated 4 .3 million fewer malaria deaths . These impressive results – particularly in sub-Saharan Africa – are due 
to a massive scale-up of malaria prevention and case management measures resulting from the combined efforts 
of national malaria control programs (NMCPs), a broad range of partners, and the launch of three major initia-
tives: the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2002, The World Bank Malaria Booster Program 
in 2004, and the U .S . President’s Malaria Initiative (PMI) in 2005 . In December 2010, the UK Department for 
International Development committed to increase its support for malaria control by up to £500 million . While 
the increased level of donor funding for malaria control during the past decade was unprecedented, it is still sig-
nificantly below the estimated US$5 .1 billion that is required annually to achieve global targets for malaria control 
and elimination . 
The scale-up of malaria control measures and the resulting decline in malaria illnesses and deaths since 2000 
has not been uniform throughout Africa . In some countries, further efforts to attain high coverage with malaria 
control interventions are needed before substantial reductions in malaria burden can be expected . In contrast, 
other countries have progressed to a point where malaria is no longer a leading public health problem . These suc-
cesses have prompted shifts in the goals and targets of many partners in the global malaria community, including 
the Bill & Melinda Gates Foundation, the Roll Back Malaria (RBM) Partnership, and WHO . While the progress to 
date is historic, the continued control and ultimate elimination of malaria remains fraught with serious challenges, 
including resistance to the artemisinin family of drugs, wide availability of substandard and counterfeit malaria 
treatments, resistance to key insecticides, inadequate disease surveillance systems, and waning country and donor 
attention as malaria burden drops . 
Brant Stewart, RTI
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When it was launched in 2005, the goal of PMI was to 
reduce malaria-related mortality by 50 percent across 15 
high-burden countries in sub-Saharan Africa through a 
rapid scale-up of four proven and highly effective malaria 
prevention and treatment measures: insecticide-treated 
mosquito nets (ITNs); indoor residual spraying (IRS); ac-
curate diagnosis and prompt treatment with artemisinin-
based combination therapies (ACTs); and intermittent 
preventive treatment of pregnant women (IPTp) . With 
the passage of the Tom Lantos and Henry J . Hyde Global 
Leadership against HIV/AIDS, Tuberculosis, and Malaria 
Act in 2008, PMI developed a U .S . Government Malaria 
Strategy for 2009–2014 . This strategy included a long-term 
vision for malaria control in which sustained high cover-
age with malaria prevention and treatment interventions 
would progressively lead to malaria-free zones in Africa, 
with the ultimate goal of worldwide malaria eradication by 
2040–2050 . Consistent with this strategy and the increase 
in annual appropriations supporting PMI, four new sub-
Saharan African countries and one regional program in the 
Greater Mekong Subregion of Southeast Asia were added 
in 2011 . The contributions of PMI, together with those of 
other partners, have led to dramatic improvements in the 
coverage of malaria control interventions in 19 PMI-sup-
ported countries, 17 of which have documented substantial 
declines in all-cause mortality rates among children less 
than five years of age . 
This updated President’s Malaria Initiative Strategy (2015–
2020) takes into account the progress over the past decade 
and the new challenges that have arisen, setting forth a vi-
sion, goal, objectives, and strategic approach for PMI through 
2020, while reaffirming the longer-term goal of worldwide 
malaria eradication . Malaria prevention and control remains 
a major U .S . foreign assistance objective, and this strategy 
fully aligns with the U .S . Government’s vision of ending 
preventable child and maternal deaths and ending extreme 
poverty . It is also in line with the goals articulated in the 
draft RBM Partnership’s second Global Malaria Action Plan 
and WHO’s draft Global Technical Strategy . 
The U .S . Government shares the long-term vision of affect-
ed countries and global partners of a world without ma-
laria . This vision will require sustained, long-term efforts to 
drive down malaria transmission and reduce malaria deaths 
and illnesses, leading to country-by-country elimination and 
eventual eradication by 2040–2050 . The U .S . Government’s 
goal is to work with PMI-supported countries and partners 
to further reduce malaria deaths and substantially decrease 
malaria morbidity, toward the long-term goal of elimina-
tion . Building upon the progress to date in PMI-supported 
countries, PMI will work with NMCPs and partners to 
accomplish the following objectives by 2020:
1 . Reduce malaria mortality by one-third from 2015 
levels in PMI-supported countries, achieving a greater 
than 80 percent reduction from PMI’s original 2000 
baseline levels .
2 . Reduce malaria morbidity in PMI-supported coun-
tries by 40 percent from 2015 levels .
3 . Assist at least five PMI-supported countries to meet 
the WHO criteria for national or sub-national pre-
elimination .
To achieve these objectives, PMI will take a strategic ap-
proach which emphasizes the following five areas: 
1 . Achieving and sustaining scale of proven interventions 
2 . Adapting to changing epidemiology and incorporat-
ing new tools 
3 . Improving countries’ capacity to collect and use infor-
mation 
4 . Mitigating risk against the current malaria control gains 
5 . Building capacity and health systems 
These areas of focus are informed by PMI’s experiences to 
date, which include building on the successes that countries 
have achieved with the support of PMI and other partners, 
incorporating the lessons learned from implementation 
thus far, and addressing directly the ongoing and new chal-
lenges that could prevent further progress toward malaria 
control and elimination . 
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II . Background
Progress in Malaria Control, 2000 to Present
The last 10–15 years have seen dramatic progress in the fight against malaria, especially in sub-Saharan Africa . 
According to its 2014 report, the World Health Organization estimated that malaria was responsible for as many 
as 198 million illnesses (range 124–238 million) and 584,000 deaths (range 367,000–755,000) worldwide in 2013 . 
More than 90 percent of all malaria deaths occur in sub-Saharan Africa, where Plasmodium falciparum, the most 
lethal species of malaria parasite, predominates . 
Scale-up of malaria control interventions between 2001 and 2013 has resulted in an estimated 4 .3 million fewer 
malaria deaths . Of these, 3 .9 million (92 percent) were in children less than five years of age in sub-Saharan Africa . 
The ten countries with the highest estimated malaria burden in 2000 accounted for 57 percent of malaria cases 
and 68 percent of malaria deaths averted between 2001 and 2013 . During the same time period, estimated ma-
laria mortality decreased by 54 percent in the WHO African Region overall and by 58 percent in children under 
the age of five .1 In Asia, the Americas, and the Pacific Islands, declining levels of transmission and the lower baseline 
prevalence of P. falciparum infections has moved a number of countries toward eliminating malaria transmission . 
These impressive results – particularly in sub-Saharan Africa where conditions are so favorable to intense, sus-
tained malaria transmission – are due, in large part, to a massive scale-up of malaria prevention and treatment 
measures resulting from the combined efforts of NMCPs and a broad range of partners . During the first half of 
the past decade, three major initiatives were launched to help control malaria: the Global Fund to Fight AIDS, Tu-
berculosis and Malaria in 2002, The World Bank Malaria Booster Program in 2004, and PMI in 2005 . In December 
2010, the U .K . Department for International Development committed to increase its support for malaria control 
by up to £500 million . These initiatives have been supported by other multilateral agencies, bilateral donors, foun-
dations, the private sector, and countless nonprofit organizations . 
The Roll Back Malaria Partnership, created in 1998 and hosted by the WHO in Geneva, has provided leadership in 
coordinating and harmonizing partners’ efforts and has successfully advocated for increased public and private sector 
CAP-Malaria
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contributions to malaria control. The Millennium Develop-
ment Goals, promulgated in 2000, helped focus the inter-
national development community’s attention on improving 
maternal and child health and combatting major infectious 
diseases, including malaria. 
These efforts have led multilateral and bilateral donors 
to sharply increase funding for global malaria control and 
elimination from less than $100 million in 2000 to an 
estimated $2.7 billion in 2013. The bulk of this support has 
been directed to sub-Saharan Africa, which accounts for the 
vast majority of malaria cases and deaths. While this repre-
sents an unprecedented level of support, the 2008–2015 
RBM Global Malaria Action Plan estimated that the global 
resource requirements to attain international targets for ma-













laria control and elimination exceed $5.1 billion annually.1
6 President’s Malaria Initiative Strategy
The President’s Malaria Initiative 
from 2005 to 2014
rapid scale-up of four proven and highly effective malaria 
prevention and treatment measures: ITNs; IRS; accurate 
diagnosis and prompt treatment with ACTs; and IPTp.
In 2008, the Tom Lantos and Henry J. Hyde Global Lead-
ership against HIV/AIDS, Tuberculosis, and Malaria Act 
authorized up to $5 billion in continued U.S. Government 
funding for malaria prevention and control through PMI. 
The Act provided for continued support to the 15 original 
PMI-supported countries, together with an expansion to 
up to seven additional countries, including Nigeria and the 
Democratic Republic of the Congo (DRC), the two largest 
malaria-endemic countries in Africa. 
PMI, which began operations in 2006, was initially ex-
pected to cover 15 countries in sub-Saharan Africa, but 
consistent with the U.S. Government Malaria Strategy 
(2009–2014) and the increase in annual appropriations 
supporting PMI, four new sub-Saharan African countries2
were added in 2011. In addition, a regional focus involving 
fi ve countries3 in the Greater Mekong Subregion of South-
In June 2005, President George W. Bush launched PMI, a east Asia was added in 2011, as evidence began to emerge 
major 5-year, $1.2 billion initiative to support a rapid scale- that resistance to ACTs was intensifying and spreading 
up of malaria prevention and treatment interventions in 15 from its original focus on the Thai-Cambodian border to 
high-burden countries in sub-Saharan Africa. The Initiative other parts of the region. 
is led by the U.S. Agency for International Development 
(USAID) and implemented together with the U.S. Depart-
ment of Health and Human Services’ Centers for Disease 
Control and Prevention (CDC). When it was launched, the 1.  World Malaria Report 2014. World Health Organization, Geneva, 2014. http://
goal of PMI was to reduce malaria-related mortality by 50 www.who.int/malaria/publications/world_malaria_report_2014/report/en/2. Democratic Republic of Congo, Guinea, Nigeria, and Zimbabwe
percent across the 15 PMI-supported countries through a 3. Burma, Cambodia, Laos, Thailand, and Vietnam
 President Bush PMI Malawi Lantos/ Launch of U.S. DRC 19 countries in Africa receiving Launch of PMI 
launches PMI begins Mozambique Hyde Government Mekong PMI support + Mekong Strategy  
operations Rwanda Act Malaria Strategy Nigeria Subregional program (2015–2020)
Senegal  (2009–2014) Guinea
Angola Zimbabwe
Tanzania
Benin |  Ethiopia | Ghana | Kenya 
Uganda
Liberia | Mali | Madagascar | Zambia
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Progress in PMI-Supported Countries
PMI’s contributions, together with those of other partners, 
have led to dramatic improvements in the coverage of 
malaria control interventions in PMI-supported countries . As 
a result of PMI’s support for ITNs, IRS, IPTp, and appropri-
ate diagnosis and treatment, a large proportion of at-risk 
populations in PMI-supported countries are now benefiting 
from highly effective malaria control measures . 
In 19 PMI-Supported Countries:
Household ownership of at least one 
ITN increased from a median of 29 
percent to 60 percent.
Usage of an ITN the night before the 
survey increased from a median of 18 
percent to 46 percent for children less 
than five years of age. 
Usage of an ITN the night before the 
survey more than doubled from a 
median of 17 percent to 41 percent for 
pregnant women.
In 13 countries, PMI’s support for IRS 
protected approximately 18 million 
people from malaria in FY 2014.
In 17 countries where IPTp is national 
policy, the proportion of pregnant 
women who received two or more 
doses of IPTp for the prevention of 
malaria increased from a median of 13 
percent to 25 percent.
All PMI-supported countries have  
adopted ACTs as their first-line  
treatment for malaria and, with PMI 
support, have procured and distributed 
more than 300 million ACT treatments 
since 2006.
Almost all PMI-supported countries 
have documented an increase in the 
percentage of malaria cases confirmed 
by diagnostic testing, including five 
countries where more than 80 percent 
of reported cases are confirmed. 
In large part, this progress can be attributed to both the 
provision of essential commodities and support of interven-
tions to build capacity of ministries of health (MOHs) and 
strengthen country health systems . PMI has played a key 
role in harmonizing planning and coordinating funding so 
that countries have a single national malaria control plan 
and budget and a unified monitoring and evaluation system, 
consistent with the Paris Declaration on Aid Effectiveness . 
Support to strengthening commodity forecasting and sup-
ply chain management systems has significantly reduced 
stockouts of malaria treatments and diagnostic tests, and 
dramatically increased the availability of quality-assured 
ACTs and rapid diagnostic tests (RDTs) at the point of care 
in PMI-supported countries . Similarly, support for strength-
ening malaria case surveillance and systems for monitor-
ing drug and insecticide resistance has enabled countries 
to more effectively select and target appropriate malaria 
control tools .
As a result, progress toward the Initiative’s goals in malaria 
control in PMI-supported countries has been impressive 
since PMI was launched . Seventeen countries have docu-
mented significant declines in all-cause mortality rates 
among children less than five years of age . These declines 
range from 18 percent (in both Liberia and Nigeria)
to 55 percent (in both Senegal and Zambia) (see map on 
page 8) .4 Impact evaluations in a subset of these countries 
strongly suggest that malaria control has made a significant 
contribution to these reductions in under-five mortality . 5
Improvement also has been seen in Nigeria and the DRC, 
which became PMI-supported countries in 2009 . Under-five 
mortality rates have dropped from 156 to 128 per 1,000 
live births between 2008 and 2013 in Nigeria and from 
148 to 104 per 1,000 live births between 2007 and 2013 in 
DRC following the significant scale-up of ITN coverage .6
In addition to providing assistance to countries to roll out 
malaria-specific activities, PMI also helps build national 
capacity in a variety of crosscutting areas that benefit both 
malaria and other health programs . This support includes 
strengthening supply chain management, training for health 
workers, and support for monitoring and evaluation sys-
tems, including disease surveillance systems . PMI also has 
placed a strong emphasis on building the skills and capacity 
of MOHs and NMCPs to manage and coordinate malaria 
control activities in their countries and strengthening the 
health systems of those countries . This has empowered 
countries to require all partners to work under a single 
Protected over 50 million people 
with a prevention measure
Distributed more than 43 million 
treatments of life-saving drugs
21 M 7 M
4 M
23,000
Coverage data are from national household surveys; see The President’s 
Malaria Initiative Ninth Annual Report to Congress for details.
4 .   The President’s Malaria Initiative: Ninth Annual Report to Congress, April 2015 . 
www .pmi .gov .
5 .   Progress & Impact Series: Focus on Mainland Tanzania . Roll Back Malaria Part-
nership, Geneva, 2012 . http://www .rollbackmalaria .org/ProgressImpactSeries/
report10 .html .
6 .   The results from DRC and Nigeria are recent . Therefore, it has yet to be 
determined what interventions, including malaria control, may have contributed 
to the reductions in all-cause child mortality .
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Reductions in All-Cause Mortality Rates of 
Children Under Five Years of Age
national malaria control plan, rather than a series of unco-
ordinated donor-driven projects .
The reductions in malaria transmission across Africa have 
had an important impact on countries’ health systems . In 
most malaria-endemic countries, an average of 25 percent 
to 35 percent of all outpatient visits and up to a third 
of admissions are for malaria in children less than five 
years of age . Where effective malaria control has been 
achieved in sub-Saharan Africa, it has resulted in many 
fewer outpatient visits and often a dramatic reduction in 
hospitalizations . For example, a PMI-funded study from 
one hospital catchment area in Zambia showed substantial 
reductions in inpatient admissions and outpatient visits for 
malaria after the scale-up of malaria control interventions . 
Hospital spending on malaria admissions also decreased 
tenfold .7 This unburdening of the health system frees up 
both health worker time and hospital beds, allowing the 
health system to function more efficiently and making it 
possible to focus a country’s often limited resources on 
other priority problems .
The Changing Epidemiology  
of Malaria
The scale-up of malaria control measures and the resulting 
decline in malarial illnesses and deaths since 2000 have 
not been uniform throughout Africa . In some countries, 
including Nigeria and the DRC (which together contribute 
approximately one-third of all malaria cases in sub-Saharan 
Africa), malaria control interventions are still being scaled 
up . Expanded efforts to scale up to high coverage with 
malaria prevention and treatment interventions will be 
needed before substantial reductions in malaria illnesses 
and deaths can be expected . 
In other countries, or areas within countries (e .g ., Ethiopia, 
Rwanda, Senegal, Zambia, and Zanzibar), malaria mortal-
ity has been reduced to low levels along with reductions 
in reported clinical cases . Ethiopia, for example, which was 
subject to periodic major malaria epidemics every five to 
seven years, has had no major malaria outbreaks in more 
than a decade . Dramatic reductions in malaria cases and 
deaths in Zanzibar have prompted the country’s national 
malaria control program to set its sights on eliminating ma-
laria from its islands . In Senegal, the national malaria control 
program has set a goal of achieving pre-elimination by 2018 . 
In the Greater Mekong Subregion, elimination of malaria 
has become the central strategy for prevention of onward 
spread of artemisinin resistance, particularly in Cambodia 
and Thailand . 
The successes seen in this subset of countries have 
spurred the global malaria community to recalibrate its 
goals and targets . For example, the Bill & Melinda Gates 
Foundation has now adopted malaria eradication as its 
primary goal . This shift also is reflected in the Roll Back 
Malaria Partnership’s draft second Global Malaria Action 
Plan 2, 2016–2030 (GMAP 2) and WHO’s draft Global 
Technical Strategy (GTS) . The global targets that these 
plans set forth for 2030 are:
•	 To	reduce	malaria	mortality	rates	globally	by	at	least	
90 percent compared with 2015
•	 To	reduce	malaria	clinical	case	incidence	globally	by	
at least 90 percent compared with 2015
•	 To	eliminate	malaria	from	at	least	30	countries	that	
had transmission of malaria in 2015 and ensure 
prevention of re-establishment in countries that are 
malaria-free 
The GTS also sets the following intermediate milestones 
for 2020:
•	 To	reduce	malaria	mortality	rates	globally	by	at	least	
40 percent compared with 2015
•	 To	reduce	malaria	clinical	case	incidence	globally	by	
at least 40 percent compared with 2015
7 .  Comfort, A .B . et al . (2014) . Hospitalizations and Costs Incurred at the Facil-
ity Level after Scale-up of Malaria Control: Pre-Post Comparisons from Two 




































Note:  All 17 PMI-supported countries 
included in this figure have at least two 
data points from nationwide 
household surveys that measured 
all-cause mortality in children under 
the age of five.
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•	 To	eliminate	malaria	from	at	least	10	countries	that	
had transmission of malaria in 2015 and ensure 
prevention of re-establishment in countries that are 
malaria free
Going forward, the President’s Malaria Initiative Strategy 
recognizes the need to tailor its support for malaria control 
activities to the evolving malaria situation in each country . 
In countries such as DRC and Nigeria, focus must remain 
on supporting the country to fully scale up current inter-
ventions, including ITNs and malaria case management . In 
countries such as Ethiopia, Rwanda, Senegal, and Zambia, 
attention will shift to building the needed systems to 
eliminate malaria from parts or all of these countries, while 
continuing to sustain core interventions, as appropriate .
New Challenges
In spite of this progress, malaria control and ultimately 
elimination face serious challenges . One of the most 
serious threats to progress in malaria control has been 
the resistance to the artemisinin family of drugs that has 
been identified in the Greater Mekong Subregion and 
possibly in South America . Artemisinin-based combi-
nation therapy is currently the first-line treatment for 
P. falciparum malaria in most countries worldwide . If 
artemisinin-resistant strains of P. falciparum arose in or 
were imported to Africa, as is thought to have occurred 
in the late 1970s with resistance to the antimalarial drug 
chloroquine, it would be catastrophic for malaria control 
on the African continent .
Further driving the development and spread of drug resis-
tance is the wide availability of substandard and counterfeit 
malaria treatments in affected countries . This is particularly 
true in private sector outlets, where the majority of malaria 
cases are treated . When such poor-quality treatments are 
used, they increase the risk of severe disease and death for 
the patient and select for resistant parasites, which then can 
be transmitted onward .
Similarly, with the successful scaling up of ITNs and IRS, 
resistance to key insecticides, including pyrethroids and 
DDT, is now being identified from a growing number of 
malaria-affected countries . This has forced many coun-
tries to switch to more costly insecticides for IRS and has 
raised concerns about the possible decrease in effective-
ness of ITNs .
Beyond these technical challenges, in many countries the 
weak health systems and lack of skilled human capacity will 
continue to slow progress toward malaria control goals and 
targets . In particular, lack of well-functioning health informa-
tion and surveillance systems will hamper evidence-based 
programming decisions . As countries continue to make 
progress in scaling up malaria control interventions, it be-
comes increasingly difficult to get needed commodities and 
services to those who have not yet been reached, including 
remote and mobile populations . 
New Opportunities
While these developments represent serious threats to 
malaria control, there is reason to be hopeful that they will 
not derail continuing progress toward reducing malaria 
burden . Within the last 10 years, a number of innovations 
have gone from the laboratory to national scale-up, includ-
ing long-lasting insecticide-treated nets, a new long-lasting 
organophosphate insecticide for IRS, and additional ACTs . 
The availability of high-quality, affordable RDTs for malaria 
has enabled countries to abandon the practice of pre-
sumptively treating every fever for malaria, better ensur-
ing that malaria treatments are reserved only for those 
infected with malaria and reducing drug pressure, which 
is a major factor in driving the establishment and spread 
of antimalarial drug resistance . The scale-up of diagnostic 
testing also improves the quality of malaria surveillance 
data, thereby enabling countries to better monitor malaria 
burden and its response to control interventions . The use 
of technology, such as mobile phones and internet, can 
improve the timeliness and the quality of malaria data and 
improved decision-making .
Innovative approaches to deploy existing tools also are 
being tested, including presumptive insecticide rotation 
to mitigate the spread and intensification of resistance . 
Seasonal malaria chemoprevention,8 which uses existing 
malaria treatments, has been shown to be efficacious in 
reducing morbidity and mortality from malaria in the West 
African Sahel . Efforts are now underway to take this inter-
vention to scale where it is recommended . 
It is anticipated that by 2020, the global malaria community 
may have entirely new classes of malaria treatments to 
replace ACTs and possibly more effective insecticide com-
binations for ITNs . There also is a real possibility of having 
a vaccine that can reduce severe morbidity and mortality 
from malaria in the near term . Better diagnostic tools and 
information technologies to facilitate program management 
and monitoring also may be within reach .
8 . http://www .who .int/malaria/publications/atoz/who_smc_policy_recommendation/en/
 10 | Ending Preventable Maternal Mortality
10     President’s Malaria Initiative Strategy
III . The President’s Malaria  
Initiative Strategy, 2015–2020
The 2008 Tom Lantos and Henry J . Hyde Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Act, 
which authorized funding for PMI through Fiscal Year (FY) 2013, called for the development of a comprehensive 
multi-year U .S . Government malaria strategy . To align with the six-year timeframe of the Global Health Initiative, 
a U .S . Government Malaria Strategy for 2009–20149 was prepared . This strategy included a long-term vision for 
malaria control in which sustained high coverage with malaria prevention and treatment interventions would 
progressively lead to malaria-free zones in East, West, and southern Africa, with the ultimate goal of worldwide 
malaria eradication by 2040–2050 . This legislation provided for the continuation of support to the original 15 
PMI-supported countries and an expansion to other endemic countries .
As the current U .S . Government Malaria Strategy comes to an end in 2014, an updated President’s Malaria Initia-
tive Strategy is needed that takes into account the progress that has been made in decreasing the burden of ma-
laria over the past decade and new challenges that have arisen, setting forth bold targets and strategic priorities 
for PMI through 2020, while reaffirming the longer-term goal of malaria eradication . 
Vision
The U .S . Government shares the long-term vision of affected countries and our global partners of a world without 
malaria . This vision, as described in the 2009–2014 Lantos-Hyde U .S . Government Malaria Strategy, will require 
sustained, long-term efforts to drive down malaria transmission and reduce malaria deaths and illnesses, leading to 
country-by-country elimination, and eventually eradication by 2040–2050 . This vision fully aligns with the long-
term goals set forth in WHO’s draft Global Technical Strategy and the Roll Back Malaria Partnership’s draft second 
Global Malaria Action Plan 2, 2016–2030 .
9 .  http://www .pmi .gov/docs/default-source/default-document-library/pmi-reports/usg_strategy2009-2014 .pdf
Erin Schiavone, Abt Associates
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Guiding Principles 
Malaria prevention and control is a major U .S . foreign 
assistance objective and an important component of a 
comprehensive U .S . Government global health strategy to 
reduce the burden of disease and strengthen communi-
ties around the world, contributing to ending extreme 
poverty . This strategy is fully aligned with the U .S . Govern-
ment’s bold vision of ending preventable child and mater-
nal deaths by 2035, as malaria continues to be a leading 
cause of child mortality, despite the progress of the last 
decade .10 Because malaria also places a heavy financial 
burden on families and affected countries, this strategy’s 
focus on reducing the burden of malaria in targeted coun-
tries further supports the U .S . Government’s high-level 
development goal of ending extreme poverty . The success 
of U .S . Government efforts to reduce malaria-related 
disease and deaths going forward is fully dependent on 
maintenance or possible expansion of current funding lev-
els in the U .S . foreign assistance budget . Assuming stable 
funding levels are provided during the period of this strat-
egy, PMI will continue its focus on those countries which 
currently receive PMI support – 19 countries in Africa 
and two countries (Burma and Cambodia) and a regional 
program in the Greater Mekong Subregion . Expansion to 
other countries or regions would only be feasible if cur-
rent appropriation levels increase .
Building on the progress and experiences of PMI dur-
ing the past nine years, the President’s Malaria Initiative 
Strategy sets out the following goal and objectives for the 
period 2015–2020: 
Goal
Work with PMI-supported countries and partners to 
further reduce malaria deaths and substantially decrease 
malaria morbidity toward the long-term goal of elimination .
Objectives
Building upon the progress made to date in PMI-support-
ed countries, PMI will work with NMCPs and partners to 
accomplish the following by 2020:
1 . Reduce malaria mortality by one-third from 2015 
levels in PMI-supported countries, achieving a 
greater than 80 percent reduction from PMI’s origi-
nal 2000 baseline levels . 
2 . Reduce malaria morbidity in PMI-supported coun-
tries by 40 percent from 2015 levels .11
3 . Assist at least five PMI-supported countries to meet 
the WHO criteria for national or sub-national pre-
elimination .12
Strategic Approach 
The President’s Malaria Initiative Strategy for 2015–2020 
builds on and reinforces the successful approach that has 
resulted in significant reductions in malaria burden since 
2006 in PMI-supported countries . Even with the demon-
strated reductions in child mortality that have been seen 
in all 17 PMI-supported countries, further reductions in 
child mortality can be achieved with PMI’s continued sup-
port . This is particularly relevant in high burden countries, 
such as Nigeria and DRC, which became part of PMI in 
the sixth year of the Initiative and where scale-up to uni-
versal coverage of malaria interventions is still underway .
PMI also must adapt to the changing epidemiology of 
malaria in its focus countries, particularly those that have 
exceeded original expectations and begun to see signifi-
cant reductions in malaria morbidity . Countries such as 
Ethiopia, Madagascar, Rwanda, Senegal, and Zambia have 
witnessed a sharp reduction in malaria cases as control 
interventions have achieved scale . Additionally, in higher 
burden countries – such as Angola and Kenya – malaria 
burden is increasingly focused in limited geographic areas 
or in specific high-risk populations that are often the most 
difficult to reach . In response, these countries, working 
with PMI and other partners, have recalibrated their goals 
and targets toward national or sub-national elimination . 
Where such goals are achievable, PMI must be responsive 
to these shifting strategies, while ensuring that resources 
are not diverted from achieving continued reductions in 
child mortality and morbidity in higher burden areas . 
PMI can particularly add value to these efforts to move 
toward pre-elimination and eventual elimination by sup-
porting countries to develop the information systems that 
will be essential in reaching those targets . Strengthening 
surveillance systems and building the capacity to collect, 
analyze, and use those data to both target interventions 
and track progress will become central to these programs . 
In addition, PMI’s support can help countries achieve 
further progress in scaling up and improving the quality of 
both IPTp and malaria case management .
 
10 .   WHO currently estimates that malaria is the seventh leading cause of 
death in low-income countries .
11 .  It should be noted that PMI’s target for reduction in malaria mortality is 
lower than those in the GTS and draft GMAP 2 (i .e . a reduction of 33 
percent vs . 40 percent) . Because most PMI-supported  countries already 
have had great success in sharply reducing all-cause child mortality over 
the last decade, further mortality reductions will be more limited in 
those PMI-supported countries when compared to the larger number 
of countries not supported directly by PMI but which are included in the 
GTS and GMAP2 mortality reduction calculations .
12 . http://whqlibdoc .who .int/publications/2007/9789241596084_eng .pdf
Erin Schiavone, Abt Associates
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Since it was launched, PMI’s approach has been to build 
capacity within countries to implement and monitor 
malaria control interventions, rather than bypass country 
systems . PMI’s experience has been that programs are 
most successful when countries own and lead malaria 
control efforts . Such country ownership leads to devel-
opment of strategies and delivery systems that are best 
tailored to the specific epidemiology and health systems 
in which they operate . In some PMI-supported countries, 
there are already examples of MOHs that have fully main-
streamed activities that were initially piloted with PMI’s 
support . PMI will continue to work with and encourage 
countries to fully integrate malaria control activities into 
their health systems and to build their capacity to manage 
these programs, thus reducing their reliance on external 
financial and/or technical support .
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IV . Core Areas of Strategic 
Focus, 2015–2020
The President’s Malaria Initiative Strategy for the next six years emphasizes the following five areas of strategic focus:
 1 . Achieving and sustaining scale of proven interventions 
 2 . Adapting to changing epidemiology and incorporating new tools
 3 . Improving countries’ capacity to collect and use information
 4 . Mitigating risk against the current malaria control gains 
 5 . Building capacity and health systems 




   control/elimination
	 •	 Continuing	to	engage	at	global	and	regional	level	to	ensure	coordination	and	adoption	of	best	practices
Erin Schiavone, Abt Associates
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1 . Achieving and Sustaining Scale  
of Proven Interventions
PMI will continue its strong support to universal coverage 
of at-risk populations with ITNs, IPTp, and case manage-
ment, and targeted high-level coverage of IRS . Whether 
countries are still scaling up core malaria control interven-
tions or have largely achieved scale, sustaining and building 
on prior achievements must be central to PMI’s efforts 
in the coming years . Well-documented past experi-
ences from Sao Tome e Principe, Sri Lanka, Zambia, and 
Zanzibar demonstrate that diverting focus from achieving 
and sustaining scale with effective prevention and control 
measures will result in resurgence of malaria morbidity 
and mortality, risking the extraordinary progress achieved 
to date and the substantial investments made .
The scale-up of long-lasting ITNs and the implementa-
tion of IRS in targeted areas are among PMI’s greatest 
accomplishments to date . This has been largely achieved 
through support for net distribution campaigns that at-
tain high levels of equitable coverage in a short period 
of time . Although such campaigns will continue to be an 
important strategy for reaching and sustaining scale, PMI 
will support national malaria control plans and partners 
to explore and implement alternative net delivery strate-
gies to fill gaps missed by campaigns . These alternative 
approaches could potentially be more cost-effective and 
sustainable ways to maintain high-level coverage . Use of 
schools, antenatal and immunization clinics, community 
health workers, and the private sector to deliver ITNs and 
community-based applications of IRS are already being 
piloted and will be scaled up if shown to be effective and 
to provide equitable coverage .
Although progress in scale-up of malaria case management 
and IPTp has lagged behind that of ITNs and IRS, rapid 
advancement has been seen in some areas . A number 
of PMI-supported countries now confirm more than 80 
percent of malaria cases with a diagnostic test, a drastic 
improvement over just a few years ago when the large 
majority of malaria cases were diagnosed solely based on 
clinical findings . In addition, intensified efforts in countries, 
such as Ghana and Zambia, have relieved some of the 
policy and health systems bottlenecks to scale up IPTp . 
Further progress is anticipated in these intervention areas 
as health systems continue to be strengthened and coun-
tries adapt successful approaches to their country context . 
This progress has been facilitated by PMI’s efforts to ad-
dress key challenges to scale-up, such as weak commodity 
forecasting and supply chains and lack of quality assurance 
systems for monitoring laboratories and clinical services . 
During the next six years, PMI will continue to identify 
and develop long-term solutions to remove impediments 
toward achieving universal coverage of these life-saving 
interventions . PMI will continue to work across the health 
sector to strengthen country health systems . 
The success of malaria control efforts also has been 
contingent on PMI’s support for effective interventions 
to educate the public and change their perception and 
behaviors related to malaria . Through behavior change, 
communications, and social mobilization interventions, 
PMI will continue to work to increase the operational 
effectiveness of our efforts by engaging families and pro-
viders in malaria control efforts . We will strive to ensure 
families seek and use malaria prevention products and 
services and to promote timely testing and adherence to 
treatment guidelines .  
2 . Adapting to Changing Epidemiol-
ogy and Incorporating New Tools
Continued focus on achieving and maintaining scale of 
existing interventions, though, does not mean business 
as usual in U .S . Government malaria assistance efforts . 
PMI is continually working with countries and the global 
malaria community to develop, adopt, and implement 
new proven tools and approaches for malaria control . 
For example, PMI played a central role in supporting 
countries to adopt integrated community case manage-
ment and universal diagnostic testing for malaria as core 
malaria control strategies . PMI also has promoted the 
safe and judicious use of insecticides in IRS by supporting 
countries to develop best management practices that es-
tablish a uniform approach for environmental protection . 
More recently, PMI is providing key support to assess the 
feasibility of delivering seasonal malaria chemoprevention 
in targeted countries .
As countries’ success in malaria control leads to changes 
in epidemiology and local strategies and targets evolve in 
response, PMI will increasingly need to adapt and tailor 
its approaches and support . This will include testing and 
scaling up new methods to access the hardest to reach 
and highest risk populations . Such approaches may include 
establishing community-based delivery systems; engag-
ing the private sector to reach those who lack access or 
avoid traditional public health structures; and targeting 
certain interventions geographically or to hard-to-reach 
populations (e .g ., migrant workers) rather than nationally, 
for optimal impact with limited resources . Adapting to the 
changing epidemiology of malaria also means recognizing 
that the effectiveness of current malaria tools may change . 
Continuous monitoring of efficacy and effectiveness of 
implemented interventions will be necessary .
The next six-year phase of PMI will undoubtedly see 
the development of new tools and implementation ap-
proaches with demonstrated effectiveness in controlling 
malaria . New treatments and vector control tools, and 
possibly vaccines, are anticipated during this next phase . 
As it did with the initial introduction of ACTs and RDTs, 
PMI’s commodity procurements, technical assistance, and 
programmatic support will ensure that countries will have 
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the assistance needed to implement and evaluate these 
new tools as they become available .
Through its prioritization and support for operational 
research, PMI also will continue to play a role in dem-
onstrating the effectiveness, feasibility, and scalability of 
new proven tools . Operational research support also will 
continue to focus on identifying best practices and inno-
vative approaches to achieving scale, relieving bottlenecks 
to implementation for both new and existing tools, and 
achieving cost efficiencies .
3 . Improving Countries’ Capacity to 
Collect and Use Information
As malaria burden drops, control efforts will need to be 
increasingly targeted to the remaining high-risk areas and 
populations . Reaching those most at-risk populations can 
only be achieved if countries have the capacity to identify 
them . To date, household surveys have been the best 
method in many countries for monitoring intervention 
coverage and child mortality . However, these surveys are 
conducted at most every three years, and thus, their data 
will not be sufficient for countries with a rapidly changing 
malaria burden . Countries will increasingly need to adjust 
their focus and targeting on a yearly, or possibly even 
monthly, basis to respond to epidemics and real-time gaps 
in coverage of key interventions . Such surveys also lack 
the necessary granularity of data that countries will need 
to differentiate areas in their country with differing levels 
of malaria burden and intervention coverage .
With PMI support, some countries – including Ethiopia, 
Rwanda, and Senegal – have already made great strides 
in strengthening routine malaria surveillance systems and 
are beginning to use the information gathered from these 
systems to make decisions on where to target IRS or 
which communities to prioritize first for ITN campaigns . 
As malaria burden continues to decrease in countries and 
these countries move toward pre-elimination, there will 
be an increasing need to track and follow up individual 
malaria cases to limit onward transmission that could lead 
to outbreaks or broader resurgence . 
Information gathered through routine disease reporting 
and health management information systems in PMI-
supported countries will become increasingly central to 
malaria program planning, management, and evaluation . 
PMI will work with countries and partners to improve 
the validity, completeness, and timeliness of reporting of 
relevant information required for malaria program plan-
ning and management, tailor them to country require-
ments, and build capacity to analyze and use those data 
for decision-making . PMI, when appropriate, will exploit 
new technologies, such as short message service-based 
reporting systems, to enable countries to have real-time 
information on malaria burden for program planning and 
response . In addition, PMI will advocate at country and 
global levels for increased transparency of data required 
for program planning and monitoring .
4 . Mitigating Risk against the  
Current Malaria Control Gains 
History tells us that our current success in malaria control 
can easily be reversed by failure of our existing tools . 
Most agree that failure of malaria eradication efforts 
of the 1960s and 1970s was primarily the result of the 
development and spread of resistance to chloroquine, 
the first-line treatment for malaria, and DDT, the primary 
insecticide used for IRS . Lack of alternative drugs and 
insecticides and failure to explore approaches to mitigate 
this resistance resulted in a resurgence of malaria, which 
ultimately led the international community to abandon its 
eradication efforts .
PMI and the global malaria community are already faced 
with the emergence of ACT resistance in the Mekong 
Subregion and resistance to multiple classes of insecti-
cides in many parts of Africa . Working with our global 
and country partners, PMI has led global efforts to en-
sure that all PMI-supported countries routinely monitor 
the efficacy of current first-line treatments . PMI also has 
played an important role, working with other partners in 
efforts to limit the spread of ACT resistance by support-
ing efforts to reduce and eliminate malaria transmission 
along the Thai-Cambodian border and other areas of the 
Mekong where resistance has been identified . Further-
more, PMI is supporting the rapid revision of treatment 
policies in areas where current first-line treatments are 
failing . With the recent identification of molecular mark-
ers for artemisinin resistance, PMI is already evaluating 
appropriate uses of this new tool to supplement our 
existing strategies for monitoring the development and 
spread of resistance .
The effectiveness of existing vector control interventions, 
including ITNs and IRS, will depend heavily on whether 
strategies can be developed to mitigate the spread and 
intensification of insecticide resistance . PMI already sup-
ports countries to monitor insecticide resistance and to 
use this information to guide the selection and deploy-
ment of insecticides . With PMI’s support, several countries 
have used data from entomologic monitoring, which has 
demonstrated resistance to pyrethroid insecticides and 
switched to new long-lasting organophosphates for IRS . 
This approach will not only improve the effectiveness of 
IRS, but also may limit or possibly reverse the intensifica-
tion of pyrethroid resistance, which will ensure the contin-
ued effectiveness of ITNs . 
During the next six years, PMI will continue to support 
such efforts to monitor and address both drug and 
insecticide resistance . In addition, identifying, testing, and 
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implementing new methods to reduce the spread and 
impact of drug and insecticide resistance must continue 
to be a priority if we hope to sustain and build upon the 
successes of PMI .
PMI also has been a global leader in its efforts to assist 
countries to identify and eliminate poor quality and coun-
terfeit malaria drugs from within their borders . Through 
PMI requirements that all malaria treatments procured 
with PMI support pass pre-shipment quality testing, 
combined with PMI’s efforts to monitor the quality of 
treatments available at service points in both the public 
and private sector, PMI has had success in removing sub-
standard drugs from the marketplace .
In addition, as countries successfully reduce malaria 
burden they often face a new challenge: waning com-
munity participation in malaria control . As the population 
perceives malaria risk to be declining, they may become 
increasingly reluctant to use ITNs or may delay seeking 
care for fever . In some countries, such fatigue has contrib-
uted to a resurgence of malaria . Increased emphasis on 
strategies to maintain appropriate behaviors and raising 
awareness of the value to the community of eliminating 
malaria must become priorities . 
5 . Building Capacity 
and Health Systems
PMI’s experience, to date, has demonstrated that malaria 
control activities have been most successful when the 
countries take ownership and lead these efforts . This 
is only fully possible when country programs possess 
appropriately-skilled human resources and the necessary 
infrastructure to plan, implement, and monitor progress of 
their malaria control activities .
A guiding principle of PMI, from its outset, has been to 
build capacity to enable countries to implement their own 
programs rather than building parallel or stand-alone sys-
tems . A significant portion of PMI’s support to countries 
is focused on building human capacity, including engaging 
communities to participate in malaria control, and ad-
dressing gaps in country health systems in the key areas 
of supply chain management, training and supervision of 
health workers, and monitoring and disease surveillance 
systems . PMI has provided the necessary resources and 
technical assistance to strengthen drug management 
systems, and for the training and deployment of tens of 
thousands of community health workers who diagnose 
and treat malaria, pneumonia, and diarrhea in sick children . 
In addition, PMI has built skills and provided essential 
information technology infrastructure for disease surveil-
lance systems, established capacity to conduct entomo-
logic monitoring in almost all countries, and enhanced 
diagnostic capacity in laboratories to improve case identi-
fication, reporting, and tracking .
Increasingly, PMI is exploring how to engage the private 
sector in malaria control activities . In addition to exist-
ing partnerships with major corporate partners, like 
ExxonMobil and Ashanti Gold, and non-governmental 
and faith-based organizations, PMI is now working with 
countries to pilot interventions to improve fever case 
management at drug shops in targeted countries . These 
retail outlets are the primary source of malaria treat-
ment in some PMI-supported countries (most notably 
DRC, Nigeria, and Uganda) .13 If malaria case management 
targets are to be achieved, these providers must improve 
their practices, including adopting the practice of routine 
diagnostic testing of all suspected malaria cases prior to 
dispensing treatment .
In the coming years, PMI will continue to work with part-
ner country counterparts to institutionalize and strength-
en technical and operational capacity in national malaria 
control programs and MOHs, as well as key local non-
governmental organizations, faith-based organizations, civil 
society, and academic partners . As partner country ma-
laria programs mature and bring the epidemic under con-
trol, PMI will tailor its approach with countries accordingly, 
taking into consideration the countries’ overall economic 
and health system development . This may entail working 
with countries to phase out direct program implementa-
tion support, while maintaining long-term technical assis-
tance and research partnerships . Governments also may 
be funded directly (in accordance with USAID policy and 
other criteria) for specific implementation activities . PMI 
will use strategic advocacy and diplomatic efforts – from 
the community to global level – to encourage sustained, 
long-term country political and financial commitment to 
malaria control efforts and eliminate bottlenecks to suc-
cessful implementation . 
13 .   ACTwatch Group, 2013 . ACTwatch Baseline and Endline Household 
Survey Results 2009-2012: Benin, Democratic Republic of Congo, Mada-
gascar, Nigeria, Uganda, Zambia . Washington, DC: Population Services 
International . Available at: www .actwatch .info 
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Maggie Hallahan
V . Critical Assumptions for Achieving 
Strategy Goal and Objectives
The goal and objectives set forth in this strategy can only be achieved if sufficient resources are made available 
to support countries to implement their programs . Consistent with the funding assumptions from the previ-
ous 2009–2014 Strategy, if less than full funding of $5 billion over this six-year period is appropriated, then the 
expected reductions in malaria burden, including in children, will be reduced . The total numbers of countries of 
focus and population targeted will be calibrated to the funding allocation to PMI . 
The strategy also depends on development of new tools, which could include more sensitive diagnostic tests, 
novel classes of malaria treatments, vaccines, and new vector control tools . New approaches for delivering these 
tools – which may include strategies such as mass drug administration, insecticide rotation to mitigate insecticide 
resistance, and the use of new information technologies to improve information management and to promote 
appropriate behaviors of providers and affected populations – also will be required . 
In addition, the impact of malaria control interventions can be greatly limited if countries suffer from civil unrest, 
humanitarian or refugee crises, or large-scale public health emergencies (e .g ., outbreak of Ebola) . In many malaria 
endemic regions, marginalized populations, such as mobile and migrant workers and ethnic minorities, suffer 
disproportionally from the burdens of malaria . In contrast, resolution of civil unrest can lead to an acceleration of 
malaria control activities, resulting in a measurable reduction of malaria burden .
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VI . PMI Core  
Operating Principles
The President’s Malaria Initiative Strategy for 2015–2020 is guided by many of the same principles that were 
established when PMI was launched . These operating principles have played a key role in PMI’s success to date 
and remain valid today . The following principles underpin the approach and success of the strategy: 
1 . Work within national malaria control strategies and plans and strengthen the capacity of national institu-
tions, host country systems, and professionals to address the challenges of malaria control, building country 
ownership and sustainability .
2 . Promote an integrated and sustainable approach to malaria prevention and control, emphasizing the com-
bined use of proven control measures, coupled with behavior change interventions and system strengthen-
ing activities based on appropriate analysis of which mix of interventions provide best value for money .
3 . Maintain sufficient flexibility and remain responsive to the ever-changing nature of malaria, tailoring efforts to 
the local epidemiologic setting . 
4 . Prioritize high-risk populations – particularly children less than five years of age, pregnant women, and 
marginalized or mobile/migrant populations – while scaling up key interventions to universal coverage, when 
appropriate . 
5 . Adopt and scale up new tools and strategies that have demonstrated effectiveness, have been recommend-
ed by  WHO, and have been endorsed by the host country government .
6 . Ensure that all commodities provided to countries are of high quality and that systems are in place to con-
tinually improve the quality of services delivered .
Maggie Hallahan
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7 . Support coordination at global level of key partners – including multilateral and bilateral institutions, affected 
countries, nonprofit and faith-based organizations, private sector partners, and academia and research institutions – 
through the RBM Partnership and other working groups and task forces to share lessons learned and best prac-
tices and ensure that investments are complementary . 
8 . Within the parameters of PMI’s bilateral country assistance approach, support countries to promote coordinated 
malaria efforts among neighboring countries and collaborate with established regional initiatives .
9 . Whenever feasible and technically indicated, increase the level of integration of malaria activities with maternal 
and child health, HIV and AIDS, tuberculosis, neglected tropical diseases activities, and the U .S . Government Global 
Health Security activities .
10 . Engage with stakeholders in other sectors – including education, agriculture, and commerce – to enhance our abil-
ity to achieve malaria control and elimination objectives .
11 . Expand and leverage public-private partnerships to increase support for malaria control .
12 . Conduct operational research that helps overcome implementation bottlenecks, tests promising new tools and  
approaches, contributes to the scale-up of malaria control activities, identifies local solutions to implementation chal-
lenges, and identifies the most cost-effective mix of proven interventions under different malaria transmission settings .
Maggie Hallahan
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VII . Coordinating U .S . Government 
Malaria Research Efforts
For many years, the U .S . Government has played a leading role in conducting and supporting research to de-
velop and test malaria control interventions, including IRS, ITNs, IPTp, and ACTs, as well as research and develop-
ment of new tools, such as malaria vaccines and new antimalarial drugs . More recently, the U .S . Government has 
provided support for development of new insecticides and vector control tools . During the next six years, it will 
be critical to maintain that strategic leadership role in both basic and applied research . 
Per the 2008 Tom Lantos and Henry J . Hyde Global Leadership against HIV/AIDS, Tuberculosis, and Malaria 
Act, the U .S . Global Malaria Coordinator has primary responsibility for the oversight and coordination of all 
resources and international activities of the U .S . Government related to efforts to combat malaria . PMI’s spe-
cific role will be to support operational and implementation research to improve the scale-up and quality of its 
control activities and support introduction of new malaria control tools . The U .S . Global Malaria Coordinator 
will ensure that operations and implementation research supported by PMI will closely complement the clinical 
and program research being undertaken across U .S . Government agencies . Consistent with the Act, CDC will 
continue to advise the Malaria Coordinator on operational research priorities and be a key implementer of 
that research . 
It is expected that existing National Institutes of Health, CDC, and Department of Defense programs will con-
tinue to develop and test new malaria prevention and control tools, as well as train qualified epidemiologists, en-
tomologists, and malaria researchers under those agencies’ intra- and extramural research and training programs . 
USAID will continue its longstanding support for malaria vaccine research and development and for antimalarial 
drug discovery and development . 
Brant Stewart, RTI
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With the changing epidemiology of malaria, questions will continue to arise about the use and cost-effectiveness of ma-
laria control measures both individually and in combination, the best mix of interventions in different epidemiologic set-
tings, and how long interventions should be continued as countries approach pre-elimination status . Information from 
operational research will also help ensure the most efficient allocation of malaria control resources as the epidemiology 
of the disease changes . 
The primary focus of PMI-supported operational research will remain on resolving problems and improving implemen-
tation of malaria prevention, treatment, and monitoring and evaluation activities . As new or improved malaria interven-
tions are developed, operational research will be required to see how they can best be incorporated into ongoing 
malaria control programs . Understanding how well and under what conditions these tools work will be critical to 
guiding cost-effective and technically sound programmatic decisions . Additionally, PMI-supported operational research 
activities will provide excellent opportunities for mentoring and building capacity among national public health workers 
and scientists . 
Brant Stewart, RTI
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VIII . PMI Governance  
and Management
The Office of the U .S . Global Malaria Coordinator, which oversees PMI, was established within USAID by the 
2008 Tom Lantos and Henry J . Hyde Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Act and 
remains permanent law . This Office will continue to oversee and coordinate the provision of U .S . Govern-
ment malaria control assistance, working with relevant executive branch agencies, including the Department of 
State, the Department of Health and Human Services, and the Department of Defense; as well as multilateral 
institutions, including the World Health Organization, the United Nations Children’s Fund, the Global Fund, U .K . 
Department for International Development, the World Bank, and the Roll Back Malaria Partnership . Within each 
PMI-supported country, the USAID Mission Director is responsible for oversight and leadership of PMI activities . 
An interagency PMI country team composed of U .S .-based and in-country USAID and CDC staff work with the 
NMCPs and other partners to develop detailed annual implementation plans (Malaria Operational Plans) that 
describe planned activities, expected results, and budgets, based on the country’s NMCP, an analysis of gaps in 
funding, and lessons learned from previous years’ activities . 
PMI places a premium on tracking how U .S . Government malaria resources are used; transparency in the way 
priorities are set and decisions are made; and achieving and documenting results . The PMI management ap-
proach stresses:
•	 Early	obligation	of	congressionally-appropriated	funds	so	that	nearly	100	percent	of	funds	are	obligated	
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•	 Maintaining	a	central	emergency	procurement	fund	including	a	small	buffer	stock	of	ACTs	to	help	prevent	stock-
outs of essential commodities at the country level 
•	 Documenting	that	procured	commodities	are	reaching	beneficiaries
•	 Ongoing	tracking	of	progress	toward	PMI	goals	and	objectives
Transparency and accountability are high priorities for PMI . All annual country Malaria Operational Plans, the President’s 
Malaria Initiative Strategy, and malaria programmatic and technical guidance documents are posted on www .pmi .gov, 
once they have been approved by the U .S . Global Malaria Coordinator . In addition, all large contracts, cooperative agree-
ments, and grants related to PMI-supported malaria activities, together with regular activity reports from implementing 
partners, are posted on the website . Furthermore, PMI reports annually to Congress on its progress and impact to date .
Erin Schiavone, Abt Associates
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